ArticlesEffect of selective decontamination on antimicrobial resistance in intensive care units: a systematic review and meta-analysis
Introduction
Hospital-acquired infections affect a quarter of critically ill patients, and can double the risk of a patient dying.1, 2 Because hospital-acquired infections are preceded by colonisation with pathogenic bacteria, prophylactic antimicrobial treatment might have the potential to reduce the burden of pathogens in a patient's respiratory and gastrointestinal tract, and thereby prevent the onset of invasive infections such as ventilator-associated pneumonia.
Selective digestive decontamination (SDD) is defined as the prophylactic application of topical, non-absorbable antimicrobials in the oropharynx and stomach, with the goal of eradicating potentially pathogenic microorganisms but preserving the protective anaerobic microbiota. Selective oropharyngeal decontamination (SOD) is the application of such treatments to only the oropharynx. SDD is usually, and SOD is rarely, accompanied by systemic antimicrobials, which might also pre-emptively treat undetected infections. We refer to SDD, SOD, or both under the umbrella term of selective decontamination.
Selective decontamination is not a new idea; it has been assessed in more than 40 randomised controlled trials, with clinical benefits summarised in many meta-analyses.3, 4, 5, 6, 7, 8, 9, 10, 11 This intervention has shown consistent reductions in hospital-acquired infection rates (most notably ventilator-associated pneumonia), and might reduce overall mortality in intensive care units (ICUs).5, 12 However, there has been little uptake of selective decontamination in ICUs and little or no endorsement in guidelines issued by professional organisations.13, 14 The barriers to uptake of selective decontamination were explored in an international survey and Delphi panel of multidisciplinary expert stakeholders, including critical care and infectious diseases specialists.15, 16 The predominant concern expressed was that use of selective decontamination will promote the development of antimicrobial-resistant pathogens.
The possibility of promoting resistance is a serious concern, especially in view of ICUs already being the epicentre of antimicrobial use and resistance within most hospitals.1 Calls for reduced antimicrobial use through improved antimicrobial stewardship are being made worldwide,17, 18 and have already shown some success in helping curtail antimicrobial resistance in some ICUs.19, 20 Proponents of selective decontamination counter that the body of research has not documented a clear signal of increased antimicrobial resistance, and that this intervention could even potentially reduce resistance rates.21
By contrast with meta-analyses assessing the effect of selective decontamination on infection and mortality rates, no such assessment has been done to measure the effect of selective decontamination on antimicrobial resistance. Therefore, we aimed to systematically review the effect of selective decontamination on rates of colonisation or infection with antimicrobial-resistant pathogens in patients in ICUs.
Section snippets
Search strategy and selection criteria
We did our systematic review and meta-analysis in accordance with the PRISMA guidelines.22 To ensure that we captured all relevant studies we searched Medline, Embase, and Cochrane databases without any restriction on date of publication, language, country, sex, age, outcome measures, and study design or study quality. Search terms for selective decontamination included “digestive decontamination”, “oral decontamination”, “oropharyngeal decontamination”, “bowel decontamination”,
Results
We identified 64 studies of selective decontamination,12, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59, 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74, 75, 76, 77, 78, 79, 80, 81, 82, 83, 84, 85, 86, 87 35 of which were included in our systematic analysis (figure 1 and table 1). The study selection criteria showed good reproducibility (unweighted κ score 0·92).
Studies of selective
Discussion
We did not detect an increased incidence of colonisation or infection with antimicrobial resistant pathogens in recipients of selective decontamination compared with non-recipients in an ICU setting. For all pathogens other than MRSA, the pooled OR estimate showed a lower level of antibiotic-resistance in patients who received selective decontamination compared with patients who did not. This reduction in resistance was statistically significant for polymyxin-resistant and third-generation
References (87)
- et al.
Selective decontamination of the digestive tract reduces bacterial bloodstream infection and mortality in critically ill patients. Systematic review of randomized, controlled trials
J Hosp Infect
(2007) - et al.
Comprehensive evidence-based clinical practice guidelines for ventilator-associated pneumonia: prevention
J Crit Care
(2008) - et al.
Triple regimen of selective decontamination of the digestive tract, systemic cefotaxime, and microbiological surveillance for prevention of acquired infection in intensive care
Lancet
(1988) - et al.
Antibiotic prophylaxis of respiratory tract infection in mechanically ventilated patients. A prospective, blinded, randomized trial of the effect of a novel regimen
Chest
(1991) - et al.
Double-blind study of selective decontamination of the digestive tract in intensive care
Lancet
(1992) - et al.
Selective decontamination with nystatin for control of a Candida outbreak in a neonatal intensive care unit
J Hosp Infect
(1993) - et al.
Decontamination digestive selective resultats d'une etude chez le polytraumamatise
Relen Urg
(1994) - et al.
Selective decontamination of the digestive tract in multiple trauma patients. A prospective double-blind, randomized, placebo-controlled study
Chest
(1996) - et al.
Selective decontamination of the digestive tract in severely burned pediatric patients
Burns
(2001) - et al.
Effects of selective decontamination of digestive tract on mortality and acquisition of resistant bacteria in intensive care: a randomised controlled trial
Lancet
(2003)